Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	664.37	716.57	-93.75
Graham Fair Price	-93.39	0.64	9.76
PEG	-909080.90	-2.37	< 0.005
Price/Book	-10.47	5.16	5.76
Price/Cash Flow	8.78	14.97	-13.76
Prices/Earnings	18496.20	238.25	-1.28
Price/Sales	55.65	7.66	4.92
Price/FCF	8.78	14.97	-13.76
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	248.20	0.09	0.02
Operating Margin	-99.03	< 0.005	-0.97
ROA	-99.44	< 0.005	-0.42
ROE	-1.12	< 0.005	-99.52
ROIC	-0.51	< 0.005	-99.30
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.34	0.14	137.27
Dividends QOQ	0.55	0.72	30.45
EBIT QOQ	-53.02	1.01	-98.10
EPS QOQ	-49.11	1.00	-97.95
FCF QOQ	-2.84	1.83	-35.61
Revenue QOQ	0.97	-0.42	-56.55
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	-0.47	27.58	5808.01
Days Sales Outstanding (DSO)	94.25	134.31	42.50
Inventory Turnover	-192.80	3.26	-98.31
Debt/Capitalization	0.54	0.44	-19.23
Quick Ratio	1.22	1.32	8.88
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	1.94	1.85	-4.79
Cash	1.27	1.03	-18.75
Capex	< 0.005	< 0.005	-57.63
Free Cash Flow	-0.81	0.64	-21.64
Revenue	2.27	1.24	-45.23
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.38	1.50	9.01
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-8.14	30.95	280.31
Naive Interpretation	Member

06 - Financial Health · Weak

Rating